Replies to post #5914 on Galena Biopharma fka GALE

[mr10001]

700 are in the study

My concern is that it is a vaccine to prevent the recurrence of breast cancer. I think the end point is a couple of years out. But if someone in the group gets cancer is the trial a failure? Does that knock out the legs from the drug?

Lots of unknowns.